{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:22:07Z","timestamp":1763018527156,"version":"3.45.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016796","name":"Adaptive Biotechnologies Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jtct.2022.08.026","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T03:01:35Z","timestamp":1662087695000},"page":"784.e1-784.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on Immunosuppression"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7221-9405","authenticated-orcid":false,"given":"Shivaprasad","family":"Manjappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3705-9850","authenticated-orcid":false,"given":"Huy Q.","family":"Phi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6412-6153","authenticated-orcid":false,"given":"Lik Wee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0039-7143","authenticated-orcid":false,"given":"Lynn","family":"Onstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darcy B.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Connelly-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2690-3799","authenticated-orcid":false,"given":"Elizabeth F.","family":"Krakow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-0911","authenticated-orcid":false,"given":"Mary E.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7665-7100","authenticated-orcid":false,"given":"Joshua A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.08.026_bib0001","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.08.026_bib0002","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.08.026_bib0003","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/annrheumdis-2021-220626","article-title":"Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression","volume":"80","author":"Prendecki","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2022.08.026_bib0004","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1681\/ASN.2021070966","article-title":"B and T cell responses after a third dose of SARS-CoV-2 vaccine in kidney transplant recipients","volume":"32","author":"Schrezenmeier","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jtct.2022.08.026_bib0005","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1038\/s41375-021-01354-7","article-title":"Response to mRNA vaccination for COVID-19 among patients with multiple myeloma","volume":"35","author":"Stampfer","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2022.08.026_bib0006","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","volume":"137","author":"Herishanu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.08.026_bib0007","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.2021012443","article-title":"Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies","volume":"138","author":"Ghione","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.08.026_bib0008","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3324\/haematol.2021.280163","article-title":"Antibody response after vaccination against SARS-CoV-2 in adults with haematological malignancies: a systematic review and meta-analysis","volume":"107","author":"Gagelmann","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.08.026_bib0009","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41375-021-01302-5","article-title":"COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey","volume":"35","author":"Ljungman","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2022.08.026_bib0010","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/s41423-021-00743-3","article-title":"SARS-CoV-2-specific T cells in infection and vaccination","volume":"18","author":"Bertoletti","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jtct.2022.08.026_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00527-21","article-title":"Evaluation of cell-based and surrogate SARS-CoV-2 neutralization assays","volume":"59","author":"Sholukh","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jtct.2022.08.026_bib0012","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00989-21","article-title":"Anti-SARS-CoV-2 antibody levels measured by the AdviseDx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity","volume":"59","author":"Bradley","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jtct.2022.08.026_bib0013","doi-asserted-by":"crossref","first-page":"47ra64","DOI":"10.1126\/scitranslmed.3001442","article-title":"Overlap and effective size of the human CD8+ T cell receptor repertoire","volume":"2","author":"Robins","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtct.2022.08.026_bib0014","doi-asserted-by":"crossref","unstructured":"Snyder TM, Gittelman RM, Klinger M, et al. Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels. medRxiv. doi: 10.1101\/2020.07.31.20165647 [preprint].","DOI":"10.1101\/2020.07.31.20165647"},{"key":"10.1016\/j.jtct.2022.08.026_bib0015","doi-asserted-by":"crossref","unstructured":"Dalai SC, Dines JN, Snyder TM, et al. Clinical validation of a novel T-cell receptor sequencing assay for identification of recent or prior SARS-CoV-2 infection [e-pub ahead of print]. Clin Infect Dis. doi:10.1093\/cid\/ciac353, accessed May 27th 2022","DOI":"10.1093\/cid\/ciac353"},{"key":"10.1016\/j.jtct.2022.08.026_bib0016","first-page":"186","article-title":"The T cell immune response against SARS-CoV-2. Nat","volume":"23","author":"Moss","year":"2022","journal-title":"Immunol"},{"key":"10.1016\/j.jtct.2022.08.026_bib0017","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/bloodadvances.2021006917","article-title":"Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients","volume":"6","author":"Haggenburg","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.08.026_bib0018","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/jama.2021.15125","article-title":"Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273","volume":"326","author":"Steensels","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2022.08.026_bib0019","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3390\/vaccines9101075","article-title":"Humoral and cellular vaccination responses against SARS-CoV-2 in hematopoietic stem cell transplant recipients","volume":"9","author":"Lindemann","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jtct.2022.08.026_bib0020","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood.2021012769","article-title":"Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy","volume":"138","author":"Dhakal","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.08.026_bib0021","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood.2021014232","article-title":"Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients","volume":"139","author":"Maillard","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.08.026_bib0022","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jtct.2022.02.018","article-title":"B Cell aplasia is the mostpowerful predictive marker for poor humoral response after BNT162b2 mRNA SARS-CoV-2 vaccination in recipients of allogeneic hematopoietic stem cell transplantation","volume":"28","author":"Jullien","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.08.026_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103705","article-title":"Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial","volume":"74","author":"Bergman","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jtct.2022.08.026_bib0024","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150070","article-title":"T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity","volume":"7","author":"Elyanow","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtct.2022.08.026_bib0025","article-title":"Differences in SARS-CoV-2 vaccine response dynamics between class-I- and class-II-specific T-cell receptors in inflammatory bowel disease","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.08.026_bib0026","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/ibd\/izac071","article-title":"The T-cell response to SARS-CoV-2 vaccination in inflammatory bowel disease is augmented with Anti-TNF therapy","volume":"28","author":"Li","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jtct.2022.08.026_bib0027","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/bloodadvances.2021006937","article-title":"Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity","volume":"6","author":"Einarsdottir","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.08.026_bib0028","doi-asserted-by":"crossref","unstructured":"Kimura M, Ferreira VH, Kothari S, et al. Safety and immunogenicity after a three-dose SARS-CoV-2 vaccine schedule in allogeneic stem cell transplant recipients [e-pub ahead of print]. Transplant Cell Ther. 2022 Oct;28(10):706.e1\u2013706.e10.","DOI":"10.1016\/j.jtct.2022.07.024"},{"key":"10.1016\/j.jtct.2022.08.026_bib0029","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41591-021-01542-z","article-title":"Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors","volume":"27","author":"Shroff","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2022.08.026_bib0030","doi-asserted-by":"crossref","unstructured":"Mohammed K, Meadows A, Hatem S, Simon V, Jayaprakash AD, Sachidanandam R. The T cell receptor repertoire reflects the dynamics of the immune response to vaccination. bioRxiv. doi:10.1101\/2021.12.09.471735 [preprint].","DOI":"10.1101\/2021.12.09.471735"},{"key":"10.1016\/j.jtct.2022.08.026_bib0031","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","article-title":"Germinal centre-driven maturation of B cell response to mRNA vaccination","volume":"604","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2022.08.026_bib0032","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2020.12.009","article-title":"T cell memory: understanding COVID-19","volume":"54","author":"Jarjour","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2022.08.026_bib0033","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1016\/j.vaccine.2022.07.006","article-title":"Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients","volume":"40","author":"Cuffel","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jtct.2022.08.026_bib0034","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/2643-3230.BCD-21-0142","article-title":"Predictors of humoral response to SARS-CoV-2 vaccination after hematopoietic cell transplantation and CAR T-cell therapy","volume":"2","author":"Tamari","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.jtct.2022.08.026_bib0035","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41409-021-01543-z","article-title":"Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination","volume":"57","author":"Trunk","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.08.026_bib0036","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jtct.2021.06.024","article-title":"Safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients after allogeneic HCT or CD19-based CART therapy-a single-center prospective cohort study","volume":"27","author":"Ram","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.08.026_bib0037","doi-asserted-by":"crossref","first-page":"938.e1","DOI":"10.1016\/j.jtct.2021.07.008","article-title":"Safety and tolerability of SARS-CoV2 emergency-use authorized vaccines for allogeneic hematopoietic stem cell transplant recipients","volume":"27","author":"Ali","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.08.026_bib0038","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.08.026_bib0039","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaoncol.2021.5942","article-title":"Neutralizing antibody testing in patients with multiple myeloma following COVID-19 vaccination","volume":"8","author":"Terpos","year":"2022","journal-title":"JAMA Oncol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722015950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722015950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:04:03Z","timestamp":1763003043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722015950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2666636722015950"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.08.026","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on Immunosuppression","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}